News

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S , to discover novel small molecule leads for multiple therapeutic…
Read More...

Charles River Laboratories International, Inc. announced that it has acquired Brains On-Line, a leading contract research organization (CRO) providing critical data that advances novel…
Read More...

Nexus Pharmaceuticals announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Isoproterenol…
Read More...

Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of Immunoglobulin A (IgA) nephropathy.…
Read More...

Achieve Life Sciences, Inc. announced the closing of its previously announced merger with OncoGenex Pharmaceuticals, as a result of which the stockholders of Achieve have become the…
Read More...

Collidion Inc. and CalAsia Pharmaceuticals, Inc., DBA Plex Pharmaceuticals announced that they have entered into a definitive agreement under which Collidion will acquire an 80% equity…
Read More...

Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area…
Read More...

Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US. The COMMEND trial will evaluate FLX-787, the Company’s co-activator of…
Read More...

SiO2 Medical Products, Inc., a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical packaging, labware, and consumables products, and Sanaria Inc., a U.S.-based…
Read More...

Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com) has entered into a clinical trial collaboration agreement…
Read More...

Zoetis Inc. and Nexvet Biopharma plc announced that Zoetis has completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody (mAb)…
Read More...

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C. The company said the approval of Maviret was…
Read More...

Otsuka Pharmaceutical Co., Ltd., a wholly owned subsidiary of Otsuka Holdings Co., Ltd. and a global holistic healthcare company dedicated to bettering the health of people worldwide,…
Read More...

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that it has entered into a global strategic license with NantCell,…
Read More...

Baxter International Inc., a global medical products company, today announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, today announced it has received approval from the…
Read More...

Jazz Pharmaceuticals plc announced that it has entered into a license agreement with XL-protein GmbH ("XLp") for the rights to develop, manufacture and commercialize products using…
Read More...

AstraZeneca and Merck & Co., Inc., known as MSD outside of the United States and Canada, announced that they have entered a global strategic oncology collaboration to co-develop and…
Read More...

Takeda Pharmaceutical Company Limited and BioSurfaces, Inc. announced today that they have entered into an agreement to initiate a research program designed to develop innovative…
Read More...

Brainstorm Cell Therapeutics announced that the California Institute for Regenerative Medicine (CIRM) has awarded Brainstorm a grant of $16 million to support the pivotal Phase 3 study…
Read More...